636 related articles for article (PubMed ID: 1660811)
21. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
[TBL] [Abstract][Full Text] [Related]
22. Phagocyte-induced antigen-specific activation of unprimed CD8+ T cells in vitro.
De Bruijn ML; Jackson MR; Peterson PA
Eur J Immunol; 1995 May; 25(5):1274-85. PubMed ID: 7539754
[TBL] [Abstract][Full Text] [Related]
23. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
Lustgarten J; Waks T; Eshhar Z
Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
[TBL] [Abstract][Full Text] [Related]
24. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
Singer A; Kruisbeek AM; Andrysiak PM
J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
[TBL] [Abstract][Full Text] [Related]
25. Peptide engineering allows cytotoxic T-cell vaccination against human papilloma virus tumour antigen, E6.
Lipford GB; Bauer S; Wagner H; Heeg K
Immunology; 1995 Feb; 84(2):298-303. PubMed ID: 7751006
[TBL] [Abstract][Full Text] [Related]
26. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic T lymphocyte responses to wild-type and mutant mouse p53 peptides.
Bertholet S; Iggo R; Corradin G
Eur J Immunol; 1997 Mar; 27(3):798-801. PubMed ID: 9079825
[TBL] [Abstract][Full Text] [Related]
28. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection.
Speiser DE; Kyburz D; Stübi U; Hengartner H; Zinkernagel RM
J Immunol; 1992 Aug; 149(3):972-80. PubMed ID: 1634779
[TBL] [Abstract][Full Text] [Related]
29. Empty MHC class I molecules come out in the cold.
Ljunggren HG; Stam NJ; Ohlén C; Neefjes JJ; Höglund P; Heemels MT; Bastin J; Schumacher TN; Townsend A; Kärre K
Nature; 1990 Aug; 346(6283):476-80. PubMed ID: 2198471
[TBL] [Abstract][Full Text] [Related]
30. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.
Schirmbeck R; Melber K; Kuhröber A; Janowicz ZA; Reimann J
J Immunol; 1994 Feb; 152(3):1110-9. PubMed ID: 8301120
[TBL] [Abstract][Full Text] [Related]
31. Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells.
Hou S; Doherty PC; Zijlstra M; Jaenisch R; Katz JM
J Immunol; 1992 Aug; 149(4):1319-25. PubMed ID: 1354233
[TBL] [Abstract][Full Text] [Related]
32. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase.
van der Burg SH; Klein MR; van de Velde CJ; Kast WM; Miedema F; Melief CJ
AIDS; 1995 Feb; 9(2):121-7. PubMed ID: 7536421
[TBL] [Abstract][Full Text] [Related]
33. Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses.
Boog CJ; Boes J; Melief CJ
Eur J Immunol; 1988 Feb; 18(2):219-23. PubMed ID: 2965021
[TBL] [Abstract][Full Text] [Related]
34. IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides.
Jefferies WA; Kolaitis G; Gabathuler R
J Immunol; 1993 Sep; 151(6):2974-85. PubMed ID: 8397249
[TBL] [Abstract][Full Text] [Related]
35. CTL escape viral variants. I. Generation and molecular characterization.
Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB
Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078
[TBL] [Abstract][Full Text] [Related]
36. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity.
Alexander-Miller MA; Burke K; Koszinowski UH; Hansen TH; Connolly JM
J Immunol; 1993 Jul; 151(1):1-10. PubMed ID: 8392095
[TBL] [Abstract][Full Text] [Related]
37. Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells.
Vasilakos JP; Michael JG
J Immunol; 1993 Mar; 150(6):2346-55. PubMed ID: 8095512
[TBL] [Abstract][Full Text] [Related]
38. The Q7 alpha 3 domain alters T cell recognition of class I antigens.
Aldrich CJ; Lowen LC; Mann D; Nishimura M; Hood L; Stroynowski I; Forman J
J Immunol; 1991 May; 146(9):3082-90. PubMed ID: 1849941
[TBL] [Abstract][Full Text] [Related]
39. Specific epitope-induced conversion of CD8+ memory cells into effector cytotoxic T lymphocytes in vitro: presentation of peptide antigen by CD8+ T cells.
Kos FJ; Müllbacher A
Eur J Immunol; 1992 Jun; 22(6):1595-601. PubMed ID: 1376266
[TBL] [Abstract][Full Text] [Related]
40. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
Buckner FS; Wipke BT; Van Voorhis WC
Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
